← Evidence map

ArticleBritish journal of haematology2014

Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.

Jason Westin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2014

2015

2016

this papercites it

Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al. | OpenQuestion